Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Phreesia, Inc.

PHRNYSE
Healthcare
Medical - Healthcare Information Services
$12.58
$-0.13(-1.02%)
U.S. Market opens in 12h 54m

Phreesia, Inc. Fundamental Analysis

Phreesia, Inc. (PHR) shows moderate financial fundamentals with a PE ratio of -129.89, profit margin of -1.16%, and ROE of -1.85%. The company generates $0.5B in annual revenue with strong year-over-year growth of 26.84%.

Key Strengths

Cash Position15.29%
Current Ratio2.44

Areas of Concern

ROE-1.85%
Operating Margin-1.87%
We analyze PHR's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 48.2/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

D
48.2/100

We analyze PHR's fundamental strength across five key dimensions:

Efficiency Score

Weak

PHR struggles to generate sufficient returns from assets.

ROA > 10%
-1.27%

Valuation Score

Excellent

PHR trades at attractive valuation levels.

PE < 25
-129.89
PEG Ratio < 2
1.09

Growth Score

Excellent

PHR delivers strong and consistent growth momentum.

Revenue Growth > 5%
26.84%
EPS Growth > 10%
25.30%

Financial Health Score

Excellent

PHR maintains a strong and stable balance sheet.

Debt/Equity < 1
0.01
Current Ratio > 1
2.44

Profitability Score

Weak

PHR struggles to sustain strong margins.

ROE > 15%
-184.64%
Net Margin ≥ 15%
-1.16%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is PHR Expensive or Cheap?

P/E Ratio

PHR trades at -129.89 times earnings. This suggests potential undervaluation.

-129.89

PEG Ratio

When adjusting for growth, PHR's PEG of 1.09 indicates fair valuation.

1.09

Price to Book

The market values Phreesia, Inc. at 2.18 times its book value. This may indicate undervaluation.

2.18

EV/EBITDA

Enterprise value stands at 30.66 times EBITDA. This signals the market has high growth expectations.

30.66

How Well Does PHR Make Money?

Net Profit Margin

For every $100 in sales, Phreesia, Inc. keeps $-1.16 as profit after all expenses.

-1.16%

Operating Margin

Core operations generate -1.87 in profit for every $100 in revenue, before interest and taxes.

-1.87%

ROE

Management delivers $-1.85 in profit for every $100 of shareholder equity.

-1.85%

ROA

Phreesia, Inc. generates $-1.27 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.27%

Following the Money - Real Cash Generation

Operating Cash Flow

Phreesia, Inc. produces operating cash flow of $62.21M, showing steady but balanced cash generation.

$62.21M

Free Cash Flow

Phreesia, Inc. produces free cash flow of $42.46M, offering steady but limited capital for shareholder returns and expansion.

$42.46M

FCF Per Share

Each share generates $0.70 in free cash annually.

$0.70

FCF Yield

PHR converts 5.95% of its market value into free cash.

5.95%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-129.89

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

1.09

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.18

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.53

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.01

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.44

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.02

vs 25 benchmark

ROA

Return on assets percentage

-0.01

vs 25 benchmark

ROCE

Return on capital employed

-0.03

vs 25 benchmark

How PHR Stacks Against Its Sector Peers

MetricPHR ValueSector AveragePerformance
P/E Ratio-129.8929.28 Better (Cheaper)
ROE-1.85%820.00% Weak
Net Margin-1.16%-19731.00% (disorted) Weak
Debt/Equity0.010.26 Strong (Low Leverage)
Current Ratio2.444.69 Strong Liquidity
ROA-1.27%-17993.00% (disorted) Weak

PHR outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Phreesia, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-87.94%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

69.27%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

48.60%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ